Azaperone

CAS: 1649-18-9

Ref. 3D-FA18061

Product Information

• Name: Azaperone
• Synonyms: 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenoneFluoperidol, 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone, 1-(4-Fluorophenyl)-4-[4-(Pyridin-2-Yl)Piperazin-1-Yl]Butan-1-One, 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-, 4-Fluoro-4-(4-(2-Pyridyl)Piperazin-1-Yl)Butyrophenone, 4′-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone, Butyrophenone, 4′-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-, Fluoperidol, NSC 170976, R-1929, Stresnil, Suicalm
• CAS: 1649-18-9

Description

Azaperone is a potent sedative-hypnotic drug that is used to treat insomnia and as an aid in the treatment of acute, severe pain. It is also used to control convulsions in animals. Azaperone belongs to the class of barbiturates and has inhibitory effects on adrenal cortical activity and is therefore able to reduce the secretion of cortisol. In humans, it reduces the production of cortisol by inhibiting its release from the adrenal glands. Azaperone also stimulates ovulation in female mammals. The detection sensitivity for azaperone can be increased by using a LC-MS/MS method, which enables the measurement of picograms per millilitre (pg/mL) levels in human serum. This method was validated using monoclonal antibody (mAb) targeting azaperone and pentobarbital sodium, a structural heart disease marker with high analytical specificity for barbiturates.

• Brand: Biosynth

Chemical properties

• Molecular weight: 327.4 g/mol
• Formula: C₁₉H₂₂FN₃O
• Purity: Min. 95%
• Color/Form: White Powder
• InChI: InChI=1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2
• InChI key: InChIKey=XTKDAFGWCDAMPY-UHFFFAOYSA-N
• SMILES: O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1